Qube Research & Technologies (QRT)
CMPX icon

Qube Research & Technologies (QRT)’s Compass Therapeutics CMPX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.5M Buy
2,550,356
+2,108,551
+477% +$12.2M 0.02% 1105
2025
Q4 		$2.37M Buy
+441,805
New +$2.04M ﹤0.01% 2185
2023
Q2 		– Sell
-162,624
Closed -$532K – 2467
2023
Q1 		$532K Buy
162,624
+99,629
+158% +$391K ﹤0.01% 1549
2022
Q4 		$317K Buy
+62,995
New +$251K ﹤0.01% 1636
2022
Q2 		– Sell
-52,842
Closed -$72K – 2573
2022
Q1 		$72K Buy
52,842
+23,789
+82% +$49.2K ﹤0.01% 2128
2021
Q4 		$92K Buy
+29,053
New +$96.3K ﹤0.01% 2154

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Qube Research & Technologies (QRT)'s CMPX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Compass Therapeutics (CMPX) stake by 477% in Q1 2026, buying an estimated $12.2M and bringing the position to 2,550,356 shares worth $13.5M. The position accounts for 0.02% of the portfolio, ranked #1105.

Qube Research & Technologies (QRT) first reported a position in CMPX in Q4 2021 and has held it in 6 quarters since. 201 funds tracked by Wall St. Rank hold CMPX as of Q1 2026.

  • Qube Research & Technologies (QRT) held 2,550,356 shares of Compass Therapeutics worth $13.5M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 2,108,551 Compass Therapeutics shares in Q1 2026, an estimated $12.2M.
  • Compass Therapeutics made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1105 holding.
  • Qube Research & Technologies (QRT) first reported a position in Compass Therapeutics in Q4 2021 and has held it in 6 quarters since.
  • 201 funds tracked by Wall St. Rank held Compass Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.